comparemela.com
  1. Home
  2. Live Updates
  3. Anatara Lifesciences - Breaking News

Latest Breaking News On - Anatara lifesciences - Page 3 : comparemela.com

Global Antibiotics Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021

Global Antibiotics Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesBoston universityUnited kingdomDana farber cancer instituteBasilea pharmaceuticaAnatara lifesciencesCrestone pharmaEli lillyAytu bioscienceAngelini pharmaEnterome bioscienceLaura woodAgency for scienceTechnology laboratoryAmerigen pharmaceuticalsBiophore pharmaceuticals

Global Antibiotics Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021

Global Antibiotics Partnering Deals Report/Directory 2021: Trends, Players and Financials 2014-2021
prnewswire.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from prnewswire.com Daily Mail and Mail on Sunday newspapers.

United statesBoston universityUnited kingdomDana farber cancer instituteBasilea pharmaceuticaAnatara lifesciencesCrestone pharmaEli lillyAytu bioscienceAngelini pharmaEnterome bioscienceLaura woodAgency for scienceTechnology laboratoryAmerigen pharmaceuticalsBiophore pharmaceuticals

Anatara Lifesciences Limited (ASX:ANR) Meet the CEO Investor Webinar - ABN Newswire (@ABN_Newswire)

Anatara Lifesciences Limited (ASX:ANR) Meet the CEO Investor Webinar - ABN Newswire (@ABN_Newswire)
abnnewswire.net - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from abnnewswire.net Daily Mail and Mail on Sunday newspapers.

Steven lydeamoreAnatara lifesciencesAnatara lifesciences limitedChief executive officerMarket eyeLifesciences limited

Anatara Lifesciences Limited (ASX:ANR) Investor Presentation - ABN Newswire (@ABN_Newswire)

Anatara Lifesciences Limited (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in humans and animals, is pleased to release to investors a copy of the presentation that Chief Executive Officer, Mr. Steven Lydeamore, will present today to investors.

Steven lydeamoreAnatara lifesciences limitedAnatara lifesciencesLifesciences limitedChief executive officerDrugs otcHealth pharm generalAsx anr

Anatara Lifesciences Limited (ASX:ANR) Launches IBS-D Clinical Trial Recruitment Website

Anatara Lifesciences Limited (ASX:ANR), a developer of evidence based solutions for gastrointestinal diseases in animals and humans, is pleased to announce the launch of its IBS-D Clinical Trial recruitment website.

Steven lydeamoreHuman research ethics committeeAnatara lifesciences limitedAnatara lifesciencesLifesciences limitedBowel syndromeGastrointestinal re programmingIrritable bowel syndromeInflammatory bowel diseaseDrugs otcHealth pharm generalAsx anrமனிதன் ஆராய்ச்சி நெறிமுறைகள் குழுஆயுள் அறிவியல் வரையறுக்கப்பட்டவைகுடல் நோய்க்குறிஇரைப்பை குடல் ரே ப்ரோக்ராமிஂக்

© 2024 Vimarsana

vimarsana © 2020. All Rights Reserved.